Main Session
Sep
29
QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation
1166 - Real-World Evidence across Prostate RT Modalities: Utilization Shifts, Toxicity and BCR in Genomic Classifier Scored Patients
Presenter(s)
Thomas Kole, MD, PhD - Valley Health System, Paramus, NJ